The role of aromatase inhibitors as first- and second-line therapy for hormone-sensitive metastatic breast cancer

William J. Gradishar*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)S14-S19
JournalCurrent Oncology
Volume10
Issue numberSUPPL. 1
StatePublished - Jun 2003

ASJC Scopus subject areas

  • Oncology

Cite this